Cargando…

Antifungal Combination of Ethyl Acetate Extract of Poincianella pluviosa (DC.) L. P. Queiros Stem Bark With Amphotericin B in Cryptococcus neoformans

Cryptococcus neoformans is the leading cause of cryptococcosis, an invasive and potentially fatal infectious disease. Therapeutic failures are due to the increase in antifungal resistance, the adverse effects of drugs, and the unavailability of therapeutic regimens in low-income countries, which lim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andriani, Gabriella Maria, Morguette, Ana Elisa Belotto, Spoladori, Laís Fernanda Almeida, Pereira, Patrícia Morais Lopes, Cabral, Weslei Roberto Correia, Fernandes, Bruna Terci, Tavares, Eliandro Reis, Almeida, Ricardo Sérgio, Lancheros, Cesar Armando Contreras, Nakamura, Celso Vataru, Mello, João Carlos Palazzo, Yamauchi, Lucy Megumi, Yamada-Ogatta, Sueli Fumie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222688/ https://www.ncbi.nlm.nih.gov/pubmed/34177839 http://dx.doi.org/10.3389/fmicb.2021.660645

Ejemplares similares

Synergistic antifungal interaction of N-(butylcarbamothioyl) benzamide and amphotericin B against Cryptococcus neoformans
por: Andriani, Gabriella Maria, et al.
Publicado: (2023)

Enhanced Cutaneous Wound Healing In Vivo by Standardized Crude Extract of Poincianella pluviosa
por: Bueno, Fernanda Giacomini, et al.
Publicado: (2016)

Anti-Inflammatory Derivatives with Dual Mechanism of Action from the Metabolomic Screening of Poincianella pluviosa
por: Domingos, Olívia da S., et al.
Publicado: (2019)

Phenotypic characteristics and transcriptome profile of Cryptococcus gattii biofilm
por: Tavares, Eliandro Reis, et al.
Publicado: (2019)

The Antibacterial and Wound Healing Properties of Natural Products: A Review on Plant Species with Therapeutic Potential against Staphylococcus aureus Wound Infections
por: Morguette, Ana Elisa Belotto, et al.
Publicado: (2023)

Hydrogel Containing Oleoresin From Copaifera officinalis Presents Antibacterial Activity Against Streptococcus agalactiae
por: Morguette, Ana Elisa Belotto, et al.
Publicado: (2019)

Effects of environmental factors on sensitivity of Cryptococcus neoformans to fluconazole and amphotericin B
por: Carlson, Tyler, et al.
Publicado: (2021)

Commensal Streptococcus agalactiae isolated from patients seen at University Hospital of Londrina, Paraná, Brazil: capsular types, genotyping, antimicrobial susceptibility and virulence determinants
por: Otaguiri, Eliane Saori, et al.
Publicado: (2013)

Antiphagocytic protein 1 increases the susceptibility of Cryptococcus neoformans to amphotericin B and fluconazole
por: Ghaffar, Muhammad, et al.
Publicado: (2019)

Effect of Eugenol against Streptococcus agalactiae and Synergistic Interaction with Biologically Produced Silver Nanoparticles
por: Perugini Biasi-Garbin, Renata, et al.
Publicado: (2015)

Synergistic Antifungal Interaction between Pseudomonas aeruginosa LV Strain Metabolites and Biogenic Silver Nanoparticles against Candida auris
por: Spoladori, Laís Fernanda de Almeida, et al.
Publicado: (2023)

De Novo Pyrimidine Biosynthesis Connects Cell Integrity to Amphotericin B Susceptibility in Cryptococcus neoformans
por: Banerjee, Dithi, et al.
Publicado: (2016)

Adaptation to Fluconazole via Aneuploidy Enables Cross-Adaptation to Amphotericin B and Flucytosine in Cryptococcus neoformans
por: Yang, Feng, et al.
Publicado: (2021)

Combined effect of furanone fluconazole and amphotericin B against biofilms formed from Cryptococcus neoformans
por: Meenakumari, Kirishnamoorthy, et al.
Publicado: (2021)

Development of a melting-curve based multiplex real-time PCR assay for simultaneous detection of Streptococcus agalactiae and genes encoding resistance to macrolides and lincosamides
por: Otaguiri, Eliane Saori, et al.
Publicado: (2018)

Antiprotozoal Activity of Benzoylthiourea Derivatives against Trypanosoma cruzi: Insights into Mechanism of Action
por: Pereira, Patrícia Morais Lopes, et al.
Publicado: (2023)

Mixed infection by Cryptococcus neoformans and Cryptococcus gattii and coinfection with paracoccidioidomycosis in PLHIV
por: de Faria Ferreira, Marcela, et al.
Publicado: (2022)

etymologia: Cryptococcus neoformans
Publicado: (2008)

The capsule of Cryptococcus neoformans
por: Casadevall, Arturo, et al.
Publicado: (2018)

In vitro and in vivo assessment of the anti-malarial activity of Caesalpinia pluviosa
por: Kayano, Ana Carolina AV, et al.
Publicado: (2011)

Triclosan Demonstrates Synergic Effect with Amphotericin B and Fluconazole and Induces Apoptosis-Like Cell Death in Cryptococcus neoformans
por: Movahed, Elaheh, et al.
Publicado: (2016)

The combination of tamoxifen with amphotericin B, but not with fluconazole, has synergistic activity against the majority of clinical isolates of Cryptococcus neoformans
por: Hai, Trieu Phan, et al.
Publicado: (2019)

Antifungal efficacy of amphotericin B encapsulated fibrin microsphere for treating Cryptococcus neoformans infection in Swiss albino mice
por: Khan, Azmat Ali, et al.
Publicado: (2016)

Activity of tannins from Stryphnodendron adstringens on Cryptococcus neoformans: effects on growth, capsule size and pigmentation
por: Ishida, Kelly, et al.
Publicado: (2009)

Cyclosporine Affects the Main Virulence Factors of Cryptococcus neoformans In Vitro
por: de Andrade, Iara Bastos, et al.
Publicado: (2023)

Antifungal Susceptibilities of Cryptococcus neoformans
por: Archibald, Lennox K., et al.
Publicado: (2004)

Environmental Status of Cryptococcus neoformans and Cryptococcus gattii in Colombia
por: Serna-Espinosa, Briggith-Nathalia, et al.
Publicado: (2021)

Impact of Resistance to Fluconazole on Virulence and Morphological Aspects of Cryptococcus neoformans and Cryptococcus gattii Isolates
por: Rossi, Suélen A., et al.
Publicado: (2016)

Correction for Banerjee et al., “De Novo Pyrimidine Biosynthesis Connects Cell Integrity to Amphotericin B Susceptibility in Cryptococcus neoformans”
por: Banerjee, Dithi, et al.
Publicado: (2023)

Cryptococcus Species Other Than Cryptococcus neoformans and Cryptococcus gattii: Are They Clinically Significant?
por: Cano, Edison J, et al.
Publicado: (2020)

Corrigendum: Impact of Resistance to Fluconazole on Virulence and Morphological Aspects of Cryptococcus neoformans and Cryptococcus gattii Isolates
por: Rossi, Suélen A., et al.
Publicado: (2016)

Mathematical modeling of pathogenicity of Cryptococcus neoformans
por: Garcia, Jacqueline, et al.
Publicado: (2008)

Cryptococcus neoformans: Tripping on Acid in the Phagolysosome
por: DeLeon-Rodriguez, Carlos M., et al.
Publicado: (2016)

Central nervous system and Cryptococcus neoformans
por: Gaona-Flores, Veronica A.
Publicado: (2013)

Adaptive Immunity to Cryptococcus neoformans Infections
por: Mukaremera, Liliane, et al.
Publicado: (2017)

AIDS-related Cryptococcus neoformans choroiditis
por: Canfield, Gregory S., et al.
Publicado: (2020)

Tools for Assessing Translation in Cryptococcus neoformans
por: Knowles, Corey M., et al.
Publicado: (2021)

Unraveling Caspofungin Resistance in Cryptococcus neoformans
por: Papon, Nicolas, et al.
Publicado: (2021)

Cryptococcus neoformans in cerebrospinal fluid and blood
por: Barros Pinto, Marco P., et al.
Publicado: (2022)

Cryptococcus neoformans–Specific and Non–Cryptococcus neoformans–Specific Antibody Profiles in Organ Transplant Recipients With and Without Cryptococcosis
por: Yoon, Hyunah, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6q656cd0bn2rimq3rmesq0d7nt